MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker
Stay updated with breaking news from Leadless Pacemaker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the...
The future of heat care is here, and Piedmont HealthCare Heart and Vascular is at the forefront.
An experimental pacemaker is able to partially recharge its own battery by using heartbeats to generate fresh electrical energy, researchers report.
SUNNYVALE, Calif., Nov. 17, 2022 /PRNewswire/ -- EBR Systems, Inc. (ASX: "EBR", "EBR Systems", or the "Company"), developer of the world's only wireless cardiac pacing system for heart failure, is pleased to announce that the Company's WiSE technology will be featured at the 15th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session in Singapore from the 18th to the 20th of November. The APHRS is a leading non-profit organisation that represents medical, allied health, and science professionals specialising in cardiac rhythm disorders in the Asia-Pa...